Web based Drug Database (1.07 Linux)

FELBINAC

Names
Common Name	FELBINAC
Other Name	FELBINAC
Pharmacological Group	NON-STEROIDAL ANTI-INFLAMMATORY DRUGS
Chemical Name	Biphenyl-4-ylacetic acid
Chemical Group

Attributes

Indications	Contraindications	Prescriber Cautions	Patient Cautions
Toxicity	Side Effects	Liver Disease	Renal Failure
Pregnancy	Lactation	Pharmacological Actions	Diagnostic Procedures
Drugs	Interactions

Indications

Musculoskeletal pain

Contraindications

Analgesic allergy
Adverse reaction to antirheumatics
Non-steroidal anti-inflammatory drugs contraindicated

Prescriber Cautions

Consult current official advice regarding FELBINAC

Patient Cautions

See information on products containing FELBINAC for specific advice for patients

Toxicity

- None Listed -

Side Effects

- None Listed -

Liver Disease

Liver disease may alter the response to drugs in several ways. Prescribing should be kept to a minimum in all patients with severe liver disease, especially if jaundice, ascites, or evidence of encephalopathy present

Renal Failure

Consider dose reduction in renal failure to avoid possibility of toxicity, increased sensitivity, and side effects

Pregnancy

Insufficient information is available on the use of FELBINAC in pregnancy. Drugs can have harmful effects on the fetus at any stage of pregnancy. Experience with many drugs is limited. FELBINAC should only be used if expected benefit outweighs possible risk

Lactation

Insufficient information available about FELBINAC in breast feeding. If treatment is essential alternative methods of feeding the infant should be considered

Pharmacological Actions

ANALGESIC effect
ANTIINFLAMMATORY effect
ANTIPYRETIC effect
CYCLOOXYGENASE INHIBITOR effect

Diagnostic Procedures

- None Listed -

Drugs containing FELBINAC

TRAXAM 3.17% foam 100g
TRAXAM 3% topical gel 100g
FELBINAC 3.17% foam
FELBINAC 3% topical gel
TRAXAM PAIN RELIEF gel 30g
Traxam gel

Interacting Ingredients

AMINOPHYLLINE
Infrequent reports of FELBINAC reducing the BRONCHODILATOR effect of AMINOPHYLLINE. Moderate risk. Avoid
BAMBUTEROL HYDROCHLORIDE
Infrequent reports of FELBINAC reducing the BRONCHODILATOR effect of BAMBUTEROL HYDROCHLORIDE. Moderate risk. Avoid
BECLOMETASONE [INHALED]
Infrequent reports of FELBINAC reducing the BRONCHODILATOR effect of BECLOMETASONE [INHALED]. Moderate risk. Avoid
BETAMETHASONE [INHALED]
Infrequent reports of FELBINAC reducing the BRONCHODILATOR effect of BETAMETHASONE [INHALED]. Moderate risk. Avoid
BUDESONIDE [INHALED]
Infrequent reports of FELBINAC reducing the BRONCHODILATOR effect of BUDESONIDE [INHALED]. Moderate risk. Avoid
BUFYLLINE
Infrequent reports of FELBINAC reducing the BRONCHODILATOR effect of BUFYLLINE. Moderate risk. Avoid
CHOLINE THEOPHYLLINATE
Infrequent reports of FELBINAC reducing the BRONCHODILATOR effect of CHOLINE THEOPHYLLINATE. Moderate risk. Avoid
CROMOGLICATE [INHALED]
Infrequent reports of FELBINAC reducing the BRONCHODILATOR effect of CROMOGLICATE [INHALED]. Moderate risk. Avoid
DIPROPHYLLINE
Infrequent reports of FELBINAC reducing the BRONCHODILATOR effect of DIPROPHYLLINE. Moderate risk. Avoid
EPHEDRINE HYDROCHLORIDE
Infrequent reports of FELBINAC reducing the BRONCHODILATOR effect of EPHEDRINE HYDROCHLORIDE. Moderate risk. Avoid
FENOTEROL HYDROBROMIDE
Infrequent reports of FELBINAC reducing the BRONCHODILATOR effect of FENOTEROL HYDROBROMIDE. Moderate risk. Avoid
FLUTICASONE [INHALED]
Infrequent reports of FELBINAC reducing the BRONCHODILATOR effect of FLUTICASONE [INHALED]. Moderate risk. Avoid
FORMOTEROL
Infrequent reports of FELBINAC reducing the BRONCHODILATOR effect of FORMOTEROL. Moderate risk. Avoid
INDACATEROL
Infrequent reports of FELBINAC reducing the BRONCHODILATOR effect of INDACATEROL. Moderate risk. Avoid
ISOETARINE HYDROCHLORIDE
Infrequent reports of FELBINAC reducing the BRONCHODILATOR effect of ISOETARINE HYDROCHLORIDE. Moderate risk. Avoid
ISOPRENALINE HYDROCHLORIDE
Infrequent reports of FELBINAC reducing the BRONCHODILATOR effect of ISOPRENALINE HYDROCHLORIDE. Moderate risk. Avoid
ISOPRENALINE SULPHATE
Infrequent reports of FELBINAC reducing the BRONCHODILATOR effect of ISOPRENALINE SULPHATE. Moderate risk. Avoid
KETOTIFEN
Infrequent reports of FELBINAC reducing the BRONCHODILATOR effect of KETOTIFEN. Moderate risk. Avoid
METHYLEPHEDRINE
Infrequent reports of FELBINAC reducing the BRONCHODILATOR effect of METHYLEPHEDRINE. Moderate risk. Avoid
MONTELUKAST
Infrequent reports of FELBINAC reducing the BRONCHODILATOR effect of MONTELUKAST. Moderate risk. Avoid
NEDOCROMIL SODIUM
Infrequent reports of FELBINAC reducing the BRONCHODILATOR effect of NEDOCROMIL SODIUM. Moderate risk. Avoid
ORCIPRENALINE
Infrequent reports of FELBINAC reducing the BRONCHODILATOR effect of ORCIPRENALINE. Moderate risk. Avoid
ORCIPRENALINE [INHALED]
Infrequent reports of FELBINAC reducing the BRONCHODILATOR effect of ORCIPRENALINE [INHALED]. Moderate risk. Avoid
PIRBUTEROL
Infrequent reports of FELBINAC reducing the BRONCHODILATOR effect of PIRBUTEROL. Moderate risk. Avoid
REPROTEROL HYDROCHLORIDE
Infrequent reports of FELBINAC reducing the BRONCHODILATOR effect of REPROTEROL HYDROCHLORIDE. Moderate risk. Avoid
RIMITEROL HYDROBROMIDE
Infrequent reports of FELBINAC reducing the BRONCHODILATOR effect of RIMITEROL HYDROBROMIDE. Moderate risk. Avoid
RITODRINE HYDROCHLORIDE
Infrequent reports of FELBINAC reducing the BRONCHODILATOR effect of RITODRINE HYDROCHLORIDE. Moderate risk. Avoid
SALBUTAMOL
Infrequent reports of FELBINAC reducing the BRONCHODILATOR effect of SALBUTAMOL. Moderate risk. Avoid
SALBUTAMOL [INHALED]
Infrequent reports of FELBINAC reducing the BRONCHODILATOR effect of SALBUTAMOL [INHALED]. Moderate risk. Avoid
SALMETEROL XINAFOATE
Infrequent reports of FELBINAC reducing the BRONCHODILATOR effect of SALMETEROL XINAFOATE. Moderate risk. Avoid
TERBUTALINE
Infrequent reports of FELBINAC reducing the BRONCHODILATOR effect of TERBUTALINE. Moderate risk. Avoid
TERBUTALINE [INHALED]
Infrequent reports of FELBINAC reducing the BRONCHODILATOR effect of TERBUTALINE [INHALED]. Moderate risk. Avoid
THEOPHYLLINE
Infrequent reports of FELBINAC reducing the BRONCHODILATOR effect of THEOPHYLLINE. Moderate risk. Avoid
TULOBUTEROL HYDROCHLORIDE
Infrequent reports of FELBINAC reducing the BRONCHODILATOR effect of TULOBUTEROL HYDROCHLORIDE. Moderate risk. Avoid
ZAFIRLUKAST
Infrequent reports of FELBINAC reducing the BRONCHODILATOR effect of ZAFIRLUKAST. Moderate risk. Avoid